NCT04617197

Brief Summary

Transcutaneous electrical nerve stimulation (TENS) is widely used for chronic pain. Recent studies showed frequency-specific microcurrent (FSM) resonant therapy was safe and effective in patients with non-specific chronic low back pain. However, there was no prospective, double-blinded randomized controlled trial to validate the clinical applicability. The goal of this trial is to verify safety and efficacy of FSM using a TENS device, Dragon Waves Resonant Home Care Electronic Nerve Stimulator-DW1330,(Taiwan Resonant Waves Research Co, Taiwan R.O.C), in 60 patients with non-specific low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 5, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

April 14, 2023

Status Verified

April 1, 2023

Enrollment Period

7 months

First QC Date

October 28, 2020

Last Update Submit

April 12, 2023

Conditions

Keywords

Transcutaneous electrical nerve stimulationnon specific chronic low back pain

Outcome Measures

Primary Outcomes (1)

  • Changes of non-specific chronic low back pain scaled by numerical rating scale

    In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10, 0 and 20 or 0 and 100 that fits best to their pain intensity \[1\]. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.

    Time point = 0 week (before treatment), 2 week (during the treatment, by a telephone follow-up) and 4 week (after a 4-week treatment )

Secondary Outcomes (1)

  • Changes of Heart rate variability

    Time point = 0 week (before treatment) and 4 week (after a 4-week treatment )

Other Outcomes (1)

  • Adverse rate

    Time period during 4-week treatment

Study Arms (3)

Variable-frequency combination 1

EXPERIMENTAL

Non disclosure

Device: Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Variable-frequency combination 2

ACTIVE COMPARATOR

Non disclosure

Device: Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Control (Placebo)

PLACEBO COMPARATOR

Non-disclosure

Device: Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Interventions

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy using (Dragon Waves Resonant Home Care Electronic Nerve Stimulator (DW-1330), Taiwan Resonance Wave Research Co., Taiwan R.O.C,)

Control (Placebo)Variable-frequency combination 1Variable-frequency combination 2

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 20-80 years old, male or female.
  • Cases with normal psychological and communication functions who can cooperate with our study.
  • Cases who are willing to sign permits and cooperate with our study including follow up and examination.
  • Cases with complete clinical data and willing to accept investigation.

You may not qualify if:

  • Cases who diagnose pregnancy within 12 months before included.
  • Cases who diagnose with malignant disease.
  • Cases with a history of epilepsy.
  • Cases who diagnose with fracture without fixation.
  • Cases who diagnose with impaired sensation or psychological function.
  • Cases whose skin condition is not feasible to accept treatment.
  • Cases with pacemaker.
  • Cases who allergic to the conductive medium
  • Cases with a major psychiatric disorder such as schizophrenia or bipolar disorder.
  • Cases with severe visual or auditory disorder.
  • Cases who cannot communicate with the Mandarin language.
  • Other mental diseases are not suitable assessed by the PI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University

Taipei, Taiwan

Location

Related Publications (3)

  • Gozani SN. Fixed-site high-frequency transcutaneous electrical nerve stimulation for treatment of chronic low back and lower extremity pain. J Pain Res. 2016 Jun 28;9:469-79. doi: 10.2147/JPR.S111035. eCollection 2016.

  • Hazime FA, de Freitas DG, Monteiro RL, Maretto RL, Carvalho NA, Hasue RH, Joao SM. Analgesic efficacy of cerebral and peripheral electrical stimulation in chronic nonspecific low back pain: a randomized, double-blind, factorial clinical trial. BMC Musculoskelet Disord. 2015 Jan 31;16(1):7. doi: 10.1186/s12891-015-0461-1.

  • Gozani SN, Ferree TC, Moynihan M, Kong X. Impact of transcutaneous electrical nerve stimulation on sleep in chronic low back pain: a real-world retrospective cohort study. J Pain Res. 2019 Feb 25;12:743-752. doi: 10.2147/JPR.S196129. eCollection 2019.

MeSH Terms

Interventions

Transcutaneous Electric Nerve Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2020

First Posted

November 5, 2020

Study Start

September 1, 2020

Primary Completion

March 31, 2021

Study Completion

March 31, 2021

Last Updated

April 14, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations